Donna Nichols Net Worth & Insider Trades
Donna Nichols - CAO/Controller, Recro Pharma, Inc
What is Donna Nichols's Net Worth?
The current estimated net worth of Recro Pharma, Inc's CAO/Controller, Donna Nichols, is estimated to be about $0 . Donna Nichols owns about 2,340 units of Recro Pharma, Inc common stock. In the last 3 years at Recro Pharma, Inc, Donna Nichols has sold an estimated value of $0 worth.
What is Donna Nichols's Past Insider Trading?
Donna Nichols's largest purchase order was 1,200 units , worth over $7.99K on May 15, 2014. In total, Donna Nichols has made about 9 transactions over 3 years of their time at Recro Pharma, Inc. Donna Nichols usually trades in December, with the busiest year in 2014. The most recent transaction was a purchase order of 1,140 units , worth over $7.39K on May 23, 2016.
Donna Nichols
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Donna Nichols's' Mailing Address?
- Mailing address is 490 Lapp Road Malvern PA 19355 PA
Recro Pharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| J. David Enloe, Jr. | 2020 | $10,577 | - | $660,001 | $400,544 | - | $1,678 | $1,072,800 |
| Ryan D. Lake | 2020 | $198,985 | $48,000 | $1,058,040 | $744,327 | $107,640 | $24,673 | $2,181,665 |
| Ryan D. Lake | 2019 | $319,777 | $69,440 | $623,276 | $334,200 | $138,880 | $44,038 | $1,529,611 |
| Gerri Henwood | 2020 | $308,654 | $111,240 | - | - | - | $21,166 | $441,060 |
| Gerri Henwood | 2019 | $553,846 | - | $2,608,537 | $1,062,199 | $360,000 | $38,402 | $4,622,984 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1588972/000156459021015283/reph-def14a_20210420.htm
What are Recro Pharma, Inc's Past Insider Trades?
Recro Pharma, Inc's most recent insider trade came on March 17, 2022 by David Enloe Jr who bought 512 units worth $1K . In the last 8 years, insiders at Recro Pharma, Inc have sold an estimated value of $26.27M and bought an estimated value of $15.87M worth of shares. Insider trading is most common in December, with the busiest year in 2017. The most active traders at the company are Ryan D. Lake, Chief Financial Officer, Geraldine Henwood, Director, and Scp Vitalife Partners Ii Lp .
Recro Pharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||